Why the study?
Does provisional stenting with an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch safely and effectively treat coronary bifurcation lesions?
Does provisional stenting with an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch safely and effectively treat coronary bifurcation lesions?
Provisional stenting using an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch is a safe and effective novel treatment for coronary bifurcation lesions.
May support this strategy for bifurcation lesions; hypothesis-generating pending randomized trials.
The combination of an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch appears to be a safe, effective and novel treatment option for bifurcation lesions.
No takes yet. Share an insight, caveat, or question.
Worthley et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: